Amplify Protein Expression and Enhance Biopharmaceutical Production

EXIN BioPharma was founded based on a proprietary technology, Exin 21. Exin 21 is a novel and unique cis-regulatory motif that enhances the expression and secretion of targeted proteins. Exin21 can boost the protein expression and secretion of different types of proteins including viral, non-viral, intracellular, structural, and secretory proteins. The addition of Exin21 significantly increases the corresponding protein expression and secretion, and the extent of such boosting power varied, with some proteins exhibiting up to hundreds of fold increase. Exin21 addition also enhances the production yields of viruses or pseudotyped viruses which could be invaluable in the fields of gene therapy and biomedical research. Thus, Exin21 has diverse applications in biotechnology areas such as production of vaccines, mAbs, and other biopharmaceuticals where mammalian cell expression systems are needed in vitro and in vivo.